|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Gritstone Oncology, Inc. (GRTS) |
|
|
$0.87 0.00 (-0.42%) as of 4:30 Thu 5/2
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
67,990,000 |
| Market
Cap: |
59.15(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.7366 - $2.9 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Gritstone bio is a biotechnology company developing targeted immunotherapies for cancer and infectious disease. Co. discovers, develops, manufactures, and delivers cancer and infectious disease immunotherapy candidates by utilizing both of its vaccine vectors, self-amplifying mRNA and chimpanzee adenovirus. Co.'s oncology programs in clinical stage development are GRANITE, an individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. Co.'s programs in clinical stage development are: CORAL, a second generation COVID-19 vaccine program and an HIV therapeutic/cure vaccine candidate that Co. is collaborating on with Gilead Sciences, Inc.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
12,000 |
12,000 |
| Total Buy Value |
$0 |
$0 |
$22,829 |
$22,829 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Webster Stephen W |
|
– • – |
2024-04-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
7% |
|
| Allen Andrew R |
PRESIDENT AND CEO |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
899,345 |
|
- |
|
| Economides Vassiliki |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
227,762 |
|
- |
|
| Jones Erin |
EVP, CHIEF OPERATING OFFICER |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
324,618 |
|
- |
|
| Cho James |
SVP, CHIEF ACCOUNTING OFFICER |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
138,644 |
|
- |
|
| Hawryluk Matthew |
EVP, CHIEF BUSINESS OFFICER |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
286,880 |
|
- |
|
| Jooss Karin |
SEE REMARKS |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
648,851 |
|
- |
|
| Economides Vassiliki |
See Remarks |
• – – |
2023-05-23 |
4 |
B |
$1.90 |
$22,829 |
D/D |
12,000 |
214,058 |
2.74 |
-7% |
|
| Economides Vassiliki |
See Remarks |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
179,058 |
202,058 |
|
- |
|
| Cho James |
Chief Accounting Officer |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
64,515 |
111,407 |
|
- |
|
| Jones Erin |
See Remarks |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
252,845 |
305,914 |
|
- |
|
| Jooss Karin |
See Remarks |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
252,763 |
630,147 |
|
- |
|
| Allen Andrew R |
President and CEO |
• • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
738,550 |
856,750 |
|
- |
|
| Hawryluk Matthew |
See Remarks |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
191,771 |
248,311 |
|
- |
|
| Economides Vassiliki |
EVP & CFO |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
23,000 |
23,000 |
|
- |
|
| Thompson Rahsaan |
EVP and General Counsel |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
19,240 |
58,698 |
|
- |
|
| Jooss Karin |
See Remarks |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
27,600 |
377,384 |
|
- |
|
| Cho James |
Chief Accounting Officer |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,400 |
43,505 |
|
- |
|
| Hawryluk Matthew |
See Remarks |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
21,612 |
53,351 |
|
- |
|
| Jones Erin |
Chief Operating Officer |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
27,169 |
53,069 |
|
- |
|
| Allen Andrew R |
President and CEO |
• • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
118,200 |
|
- |
|
| Jones Erin |
Chief Operating Officer |
• – – |
2021-12-01 |
4 |
AS |
$13.01 |
$13,010 |
D/D |
(1,000) |
45,900 |
|
-69% |
|
| Jones Erin |
Chief Operating Officer |
• – – |
2021-12-01 |
4 |
OE |
$0.35 |
$345 |
D/D |
1,000 |
46,900 |
|
- |
|
| Jones Erin |
Chief Operating Officer |
• – – |
2021-11-01 |
4/A |
AS |
$11.14 |
$11,140 |
D/D |
(1,000) |
45,900 |
|
- |
|
| Jones Erin |
Chief Operating Officer |
• – – |
2021-11-01 |
4/A |
OE |
$0.35 |
$345 |
D/D |
1,000 |
46,900 |
|
- |
|
74 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
